# Integrated University of Puerto Rico Clinical Trials Unit

> **NIH NIH UM1** · UNIVERSITY OF PUERTO RICO MED SCIENCES · 2021 · $100,000

## Abstract

Abstract
The University of Puerto Rico Medical Sciences Campus (UPR-MSC), has invested in infrastructure and
fostered scientists to implement an impressive HIV/AIDS enterprise, covering the full spectrum of
translational research. Mostly funded by NIH, the investigators from the MSC have notable achievements
and have demonstrated capacity to sustain and expand research activities. One of our strength is the
longstanding commitment of scientists and communities to jointly participate in HIV-related clinical,
behavior and prevention trials. The investigators who are the leaders for this applicatio n: Integrated UPR
Clinical Trials Unit (IUPR-CTU), have three decades of experience, have created research and care
capacity, and are involved in mentoring the next generation of scientists (i.e. UPR Mentoring Institute for
HIV and Mental Health: PI Zorrilla) and through specific network activities such as: IUPR CTU-PI/PD
Carmen D. Zorrilla; ACTG-CRS-PI Jorge Santana and IMPAACT-CRS-PI Irma Febo. In order to address
our specific aims, we will continue the operations of the IUPR-CTU which has been in existence in various
forms for the past three decades. The IUPR-CTU is the evolution and integration of three separate and
previously independent research units that were established with specific scientific agendas for to target
populations which were key during the early years of the epidemic (pregnant women, infants, children and
adolescents; and adults living with HIV), and that still need provision. The IUPR-CTU will continue to
facilitate access to clinical and prevention clinical trials to a large number of participants of Hispanic
ethnicity living in Puerto Rico. By participating in clinical trials of new drugs or combinations of drugs many
patients have been exposed and received life-saving interventions prior to their commercial availability. In
addition, the diversity of the patients recruited nationally has been expanded to represent the race, ethnicity
and geographic location mostly affected by the epidemic. The IUPR-CTU will contribute to the research
agenda of the NIH sponsored networks (ACTG, IMPAACT and HPTN) by sharing and aligning our
infrastructure, our capacity and experience, our access to key populations, our community partnerships
and support, and our commitment to investigators, staff and institutions with the goals of the networks,

## Key facts

- **NIH application ID:** 10057009
- **Project number:** 2UM1AI069415-16
- **Recipient organization:** UNIVERSITY OF PUERTO RICO MED SCIENCES
- **Principal Investigator:** IRMA Luz FEBO
- **Activity code:** UM1 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $100,000
- **Award type:** 2
- **Project period:** 2007-02-01 → 2021-11-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10057009

## Citation

> US National Institutes of Health, RePORTER application 10057009, Integrated University of Puerto Rico Clinical Trials Unit (2UM1AI069415-16). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10057009. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*